These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 23911321)

  • 1. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.
    Chan CH; Morrow JK; Li CF; Gao Y; Jin G; Moten A; Stagg LJ; Ladbury JE; Cai Z; Xu D; Logothetis CJ; Hung MC; Zhang S; Lin HK
    Cell; 2013 Aug; 154(3):556-68. PubMed ID: 23911321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual drug design: Skp1-Skp2 inhibition targets cancer stem cells.
    Pascal LE; Wang Z
    Asian J Androl; 2013 Nov; 15(6):717-8. PubMed ID: 24077600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skp2: a dream target in the coming age of cancer therapy.
    Chan CH; Morrow JK; Zhang S; Lin HK
    Cell Cycle; 2014; 13(5):679-80. PubMed ID: 24526126
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomics and chemical library screens reveal a novel SCF
    Malek E; Abdel-Malek MA; Jagannathan S; Vad N; Karns R; Jegga AG; Broyl A; van Duin M; Sonneveld P; Cottini F; Anderson KC; Driscoll JJ
    Leukemia; 2017 Mar; 31(3):645-653. PubMed ID: 27677741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.
    Chen Q; Xie W; Kuhn DJ; Voorhees PM; Lopez-Girona A; Mendy D; Corral LG; Krenitsky VP; Xu W; Moutouh-de Parseval L; Webb DR; Mercurio F; Nakayama KI; Nakayama K; Orlowski RZ
    Blood; 2008 May; 111(9):4690-9. PubMed ID: 18305219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.
    Ungermannova D; Lee J; Zhang G; Dallmann HG; McHenry CS; Liu X
    J Biomol Screen; 2013 Sep; 18(8):910-20. PubMed ID: 23589337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific small molecule inhibitors of Skp2-mediated p27 degradation.
    Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ
    Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer.
    He DH; Chen YF; Zhou YL; Zhang SB; Hong M; Yu X; Wei SF; Fan XZ; Li SY; Wang Q; Lu Y; Liu YQ
    Cancer Sci; 2021 Aug; 112(8):3218-3232. PubMed ID: 34080260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Inhibition of the E3 Ligase SCF
    Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
    Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
    Masumoto K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
    Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
    Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
    Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
    Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis.
    Wang G; Chan CH; Gao Y; Lin HK
    Chin J Cancer; 2012 Apr; 31(4):169-77. PubMed ID: 22200179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
    Kitagawa K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor.
    Cheng X; Liu YQ; Wang GZ; Yang LN; Lu YZ; Li XC; Zhou B; Qu LW; Wang XL; Cheng YX; Liu J; Tao SC; Zhou GB
    Oncotarget; 2017 Jan; 8(2):2681-2693. PubMed ID: 27835873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 Inhibitors: Novel Anticancer Strategies.
    Lee Y; Lim HS
    Curr Med Chem; 2016; 23(22):2363-79. PubMed ID: 27160538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy.
    Hao Z; Huang S
    Front Biosci (Landmark Ed); 2015 Jan; 20(3):474-90. PubMed ID: 25553462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.
    Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP
    Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma.
    Wang J; Huang Y; Guan Z; Zhang JL; Su HK; Zhang W; Yue CF; Yan M; Guan S; Liu QQ
    Oncotarget; 2014 Jul; 5(14):5591-601. PubMed ID: 25015320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.
    Chan CH; Li CF; Yang WL; Gao Y; Lee SW; Feng Z; Huang HY; Tsai KK; Flores LG; Shao Y; Hazle JD; Yu D; Wei W; Sarbassov D; Hung MC; Nakayama KI; Lin HK
    Cell; 2012 May; 149(5):1098-111. PubMed ID: 22632973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.